Radius Health and fitness to Existing at the 39th Once-a-year J.P. Morgan Healthcare Meeting
Press launch material from World Newswire. The AP information personnel was not involved in its generation.
Press launch written content from World Newswire. The AP information staff members was not included in its development.
BOSTON, Jan. 06, 2021 (Globe NEWSWIRE) — Radius Overall health, Inc. (Nasdaq: RDUS), these days declared that Kelly Martin, President and CEO will existing a digital corporate update at the 39th Annual J.P. Morgan Healthcare Conference on Wednesday, January 13 at 9:10 a.m. EST.
A are living webcast of the presentation will be out there by checking out the Traders segment of Radius’ internet site at https://ir.radiuspharm.com/events-and-shows. A replay of the webcast will be archived on Radius’ site for 90 times subsequent the presentation.
About Radius
Radius is a science-driven thoroughly integrated biopharmaceutical enterprise that is fully commited to developing and commercializing revolutionary endocrine therapeutics. Radius’ guide product or service, TYMLOS (abaloparatide) injection, was accepted by the U.S. Meals and Drug Administration for the treatment method of postmenopausal gals with osteoporosis at higher possibility for fracture. The Radius clinical pipeline involves the investigational use of abaloparatide injection for the procedure of males with osteoporosis, an investigational abaloparatide-patch for opportunity use in osteoporosis and the investigational drug elacestrant (RAD1901) for possible use in hormone-receptor good breast cancer out-certified to Menarini Team. For more information, you should visit www.radiuspharm.com
Trader & Media Relations Get hold of:
Peter Schwartzman
Email: [email protected]
Telephone: (617) 583-2017
